Health Care/Hospital

EW GROUP SHINES AT 12TH A4M SYMPOSIUM 2023 & "ALL-ON BIOREGEN OPTIMIZATION" WORKSHOP

BANGKOK, April 13, 2023 /PRNewswire/ -- European Wellness Biomedical Group (EW Group) made a successful showing at an exclusive event, the 12th A4M Symposium 2023, which was held in Centara,Bangkok, 16th-19th February 2023. The two-day A4M Symposium, commenced with a welcome ceremony featuring ...

2023-04-13 12:20 2474

Viva Biotech Attended SAPA-China

HONG KONG, April 12, 2023 /PRNewswire/ -- 6th-7th April, the "2022 SAPA-China Annual Conference - Opportunities and Challenges for the Development ofChina's Biopharmaceutical Industry" hosted by The Sino-American Pharmaceutical Professionals Association (SAPA) was held inChengdu, Sichuan. Viva Bi...

2023-04-13 11:33 2105

Smart Physiotherapy Systems: One-Stop Solution for Pain Patients

WUHAN, China, April 12, 2023 /PRNewswire/ -- Rhein Laser Technologies Ltd., a leading manufacturer of innovative medical lasers for urologic, aesthetic and physiotherapy markets based inWuhan and Dusseldorf, reported the great improvement of Smart Physiotherapy Systems that were launched several ...

2023-04-13 11:10 1577

MIM Software Celebrates MTIC's First Total-Body PET/CT Scanner

The Melbourne Theronastic Innovation Centre, in partnership with Siemens Healthineers and MIM Software, will provide patients with access to a platform that will facilitate faster prognosis and personalized therapy using the world's most sensitive whole-body PET/CT scanner. CLEVELAND, April 13, ...

2023-04-13 10:48 1862

Altair to Showcase Pharmaceutical Process Optimization Technology at the Korea Pharm&Bio 2023

Altair will feature pharmaceutical manufacturing process simulation and data analytics technologies SEONGNAM, South Korea, April 13, 2023 /PRNewswire/ -- Altair (Nasdaq: ALTR), a global leader in computational science and artificial intelligence (AI), will be exhibiting at Korea Pharm&Bio,April ...

2023-04-13 08:00 2945

Bridge Biotherapeutics Announces First Patient Dosed in its Phase 2a Clinical Trial of BBT-877, a Potent Autotaxin Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis

SEONGNAM, South Korea and CAMBRIDGE, Mass., April 12, 2023 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a clinical-stage biotech company based in South Korea developing novel drugs for fibrosis, cancer, and inflammation, announced it has dosed the first patient in its Phase 2a clinical study...

2023-04-13 06:00 1672

Standigm announces Younsung Choo as chief executive officer

Former LG life Sciences exec and long-time Standigm advisor brings extensive experience in pharmaceuticals and project management SEOUL, South Korea, April 12, 2023 /PRNewswire/ -- Standigm , a company using artificial intelligence (AI) technology for drug discover...

2023-04-13 00:07 1870

LBB Specialties Announces Senior Vice President for Life Sciences

NORWALK, Conn., April 12, 2023 /PRNewswire/ -- LBB Specialties (LBBS), a leader inspecialty chemicals and ingredients distribution in North America, announced Seth Burns has joined LBB Specialties as Senior Vice President, Life Sciences. In his new role, Burns will be responsible for establishing...

2023-04-12 22:45 2079

NCCN Annual Conference Brings Up Important Questions for Improving Cancer Care

National Comprehensive Cancer Network's yearly conference for interdisciplinary healthcare providers focused on applying the latest evidence-based recommendations and fostering welcoming environments for patients and staff that lead to better treatment, outcomes, and quality-of-life for people wi...

2023-04-12 22:16 2006

Edanz Acquires Scribendi

Creation of a Global Leader in Scientific Editing and Language Services TOKYO and FUKUOKA, Japan, and CHATHAM-KENT, ON, April 12, 2023 /PRNewswire/ -- Edanz Inc., a leading provider of author and researcher services for the global scientific community, today announced the acquisition of Scribendi...

2023-04-12 21:47 2376

Health In Tech Partners With 6 Degrees Health to Accelerate Implementation of Level-Funded Health Plans with Transparency, Control, and Predictability

Brokers and Employers with groups ranging from 5-150 lives will benefit from the partnership's fully integrated, solution-based products for the level-funded healthcare market. STUART, Fla., April 12, 2023 /PRNewswire/ -- Health in Tech ("HIT", or "the Company"), the industry-leading insurtech c...

2023-04-12 20:30 1569

Sirnaomics Launches Phase I Clinical Trial for GalNAc Factor XI Program

Study commences following green light from the U.S. FDA for Investigational New Drug Application HONG KONG, GERMANTOWN, Md. and SUZHOU, China, April 12, 2023 /PRNewswire/ --  Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, together with its subsidiaries, the"Group" or "Sirnaomics"), a leadin...

2023-04-12 16:25 2316

CHITOSE Group Obtains Funding from Japanese Government-affiliated NEDO for Green Innovation Fund of USD400M Range

KAWASAKI, Japan and SINGAPORE, April 12, 2023 /PRNewswire/ -- Chitose Laboratory Corp., the core company of the CHITOSE Group (hereinafter "CHITOSE"), has won funding from a Japanese government-affiliated entity for a project on the self-proposed theme of "Building a global industry originating ...

2023-04-12 14:17 1717

LONGi donates 20kW of Hi-MO 6 modules to Beirut hospital

BEIRUT, April 12, 2023 /PRNewswire/ -- LONGi has announced that it has donated 20kW of its newest module product, the Hi-MO 6, toBeirut's Al Zaharaa hospital, in collaboration with AGS International, its local distributor. The project, which is expected to be completed during April, will mark the...

2023-04-12 10:49 1728

Specialised Therapeutics signs partnership agreement with Akeso Inc. and CTTQ-Akeso to commercialise new anti-PD1 antibody in Australia and Southeast Asia

SINGAPORE, April 11, 2023 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics Asia Pte Ltd (ST) will partner with CTTQ-Akeso ( Shanghai) Biomed. Tech. Co., Ltd. (CTTQ-Akeso)(jointly established by Akeso, Inc. (9926.HK, Akeso) and Chia Tai Tianqing Pharmaceutical Group Co...

2023-04-12 06:00 1947

WORLD BRAIN DAY 2023: PUTTING A SPOTLIGHT ON BRAIN HEALTH AND DISABILITY

LONDON, April 11, 2023 /PRNewswire/ -- The World Federation of Neurology (WFN) is pleased to announceBrain Health and Disability as the theme for its 10th Annual World Brain Day (WBD) onSaturday, July 22. This year's theme will inspire a global initiative to close the gaps in disability awareness...

2023-04-11 21:20 2256

DISCOVERY LIFE SCIENCES ACQUIRES REACHBIO RESEARCH LABS

Acquisition to enhance cell biology capabilities and accelerate assessments of potential new drug targets HUNTSVILLE, Ala., April 11, 2023 /PRNewswire/ -- Discovery Life Sciences™  (Discovery), the Biospecimen and Biomarker Specialists™, has acquired Seattle -basedReachBio Research Labs (ReachBio...

2023-04-11 21:05 2625

Lunit Demonstrates Progress in the Development of Novel Diagnostics at the 2023 AACR Annual Meeting

* Lunit and collaborators demonstrate key progress in the development of novel diagnostics for cancer therapies, including immuno-oncology, in addition to molecular targeted agents and antibody-drug conjugates * Presentations to deliver new research using Lunit SCOPE in a wide range of cancer...

2023-04-11 21:00 1799

Inotiv Applauded by Frost & Sullivan as Key Competitor in the Bio-analytical Testing Services Market

Inotiv offers fit-for-purpose drug testing approaches and quality-by-design methodologies to facilitate sample analysis accuracy, boosting clients' success rates. SAN ANTONIO, April 11, 2023 /PRNewswire/ -- Recently, Frost & Sullivan assessed the bio-analytical testing services industry and, bas...

2023-04-11 21:00 3181

Origin Agritech GMO Corn Hybrid is the One and Only Triple Stack Trait Corn Selected for National Demo Plot, Being Grown There in Anticipation of 2023 Commercial Launch

BEIJING, April 11, 2023 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), announced today that its GMO corn hybrid is the one and only triple stacked trait corn selected for the national demo plot and is currently being grown there in anticipation of a 2023 commerci...

2023-04-11 20:45 1715
1 ... 174175176177178179180 ... 809